We observed that HLA-DRB1*15 was significantly associated with symptomatic infection, and HLA-DRB1*13 and 15 were associated with mild to severe degrees of COVID-19 disease, which suggests both alleles may link with a robust immune response and seroconversion. This evidence concerns the gene HLA-DRB1 and infection.